Nasser, Joseph
Bergman, Drew T. http://orcid.org/0000-0002-8314-7088
Fulco, Charles P.
Guckelberger, Philine http://orcid.org/0000-0002-1057-2518
Doughty, Benjamin R.
Patwardhan, Tejal A.
Jones, Thouis R.
Nguyen, Tung H.
Ulirsch, Jacob C. http://orcid.org/0000-0002-7947-0827
Lekschas, Fritz http://orcid.org/0000-0001-8432-4835
Mualim, Kristy
Natri, Heini M.
Weeks, Elle M. http://orcid.org/0000-0002-4317-4444
Munson, Glen
Kane, Michael
Kang, Helen Y.
Cui, Ang http://orcid.org/0000-0002-1087-8568
Ray, John P. http://orcid.org/0000-0001-7294-4260
Eisenhaure, Thomas M.
Collins, Ryan L. http://orcid.org/0000-0003-1268-9995
Dey, Kushal
Pfister, Hanspeter
Price, Alkes L. http://orcid.org/0000-0002-2971-7975
Epstein, Charles B. http://orcid.org/0000-0001-8358-8345
Kundaje, Anshul http://orcid.org/0000-0003-3084-2287
Xavier, Ramnik J. http://orcid.org/0000-0002-5630-5167
Daly, Mark J. http://orcid.org/0000-0002-0949-8752
Huang, Hailiang
Finucane, Hilary K. http://orcid.org/0000-0003-3864-9828
Hacohen, Nir http://orcid.org/0000-0002-2349-2656
Lander, Eric S. http://orcid.org/0000-0003-2662-4631
Engreitz, Jesse M. http://orcid.org/0000-0002-5754-1719
Article History
Received: 20 August 2020
Accepted: 11 March 2021
First Online: 7 April 2021
Competing interests
: J.M.E., C.P.F. and E.S.L. are inventors on a patent application on CRISPR methods filed by the Broad Institute related to this work (16/337,846). Until recently, E.S.L. served on the Board of Directors for Codiak BioSciences and Neon Therapeutics; served on the Scientific Advisory Board of F-Prime Capital Partners and Third Rock Ventures; was affiliated with several non-profit organizations including serving on the Board of Directors of the Innocence Project, Count Me In and Biden Cancer Initiative, and the Board of Trustees for the Parker Institute for Cancer Immunotherapy; and served on various federal advisory committees. E.S.L. is currently on leave from MIT and Harvard. C.P.F. is now an employee of Bristol Myers Squibb. T.A.P. is now an employee of Boston Consulting Group. R.J.X. is a cofounder of Jnana Therapeutics and Celsius Therapeutics. M.J.D. is a founder of Maze Therapeutics. N.H. holds equity in BioNTech and consults for Related Therapeutics. All other authors declare no competing interests.